298 related articles for article (PubMed ID: 17718519)
21. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
[TBL] [Abstract][Full Text] [Related]
23. Substrate binding mode and its implication on drug design for botulinum neurotoxin A.
Kumaran D; Rawat R; Ahmed SA; Swaminathan S
PLoS Pathog; 2008 Sep; 4(9):e1000165. PubMed ID: 18818739
[TBL] [Abstract][Full Text] [Related]
24. How botulinum and tetanus neurotoxins block neurotransmitter release.
Humeau Y; Doussau F; Grant NJ; Poulain B
Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
[TBL] [Abstract][Full Text] [Related]
25. Tetanus and botulism neurotoxins: a novel group of zinc-endopeptidases.
Tonello F; Morante S; Rossetto O; Schiavo G; Montecucco C
Adv Exp Med Biol; 1996; 389():251-60. PubMed ID: 8861019
[TBL] [Abstract][Full Text] [Related]
26. Construction of functional chimeras of syntaxin-1A and its yeast orthologue, and their application to the yeast cell-based assay for botulinum neurotoxin serotype C.
Shao K; Wang Q; Wang N; Gao XD; Nakanishi H
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129396. PubMed ID: 31302181
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of substrate recognition by botulinum neurotoxin serotype A.
Chen S; Kim JP; Barbieri JT
J Biol Chem; 2007 Mar; 282(13):9621-9627. PubMed ID: 17244603
[TBL] [Abstract][Full Text] [Related]
28. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
29. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
30. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
Arndt JW; Jacobson MJ; Abola EE; Forsyth CM; Tepp WH; Marks JD; Johnson EA; Stevens RC
J Mol Biol; 2006 Sep; 362(4):733-42. PubMed ID: 16938310
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of tetanus and botulinum neurotoxins.
Montecucco C; Schiavo G
Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
[TBL] [Abstract][Full Text] [Related]
32. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
Chen S; Hall C; Barbieri JT
J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
[TBL] [Abstract][Full Text] [Related]
33. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
Binz T; Blasi J; Yamasaki S; Baumeister A; Link E; Südhof TC; Jahn R; Niemann H
J Biol Chem; 1994 Jan; 269(3):1617-20. PubMed ID: 8294407
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
35. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.
Sakaba T; Stein A; Jahn R; Neher E
Science; 2005 Jul; 309(5733):491-4. PubMed ID: 16020741
[TBL] [Abstract][Full Text] [Related]
36. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
37. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5.
Kalb SR; Baudys J; Webb RP; Wright P; Smith TJ; Smith LA; Fernández R; Raphael BH; Maslanka SE; Pirkle JL; Barr JR
FEBS Lett; 2012 Jan; 586(2):109-15. PubMed ID: 22172278
[TBL] [Abstract][Full Text] [Related]
39. A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.
Fang H; Luo W; Henkel J; Barbieri J; Green N
Proc Natl Acad Sci U S A; 2006 May; 103(18):6958-63. PubMed ID: 16636286
[TBL] [Abstract][Full Text] [Related]
40. [Action mechanisms of botulinum neurotoxins and tetanus neurotoxins].
Deloye F; Doussau F; Poulain B
C R Seances Soc Biol Fil; 1997; 191(3):433-50. PubMed ID: 9295967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
